Multiple Sclerosis Clinical Trial

Virtual Reality (VR) to Improve Quality of Life in Patients Diagnosed With Neurological Disorders

Summary

Participants with neurological disorders will be recruited to complete sessions of virtual reality (VR) immersion. VR has been shown to have therapeutic benefit in certain patient populations and requires further clinical study to determine the extent to which VR can be used to rehabilitate and reduce symptom burden. This study seeks to pilot newly developed VR methods and collect preliminary data in order to support research grants and inform larger clinical trials. Additionally, this proposed study will explore the tolerability and preliminary efficacy of Virtual Reality (VR), specifically to determine whether VR can acutely reduce the severity of symptom burden caused by neurological disorders.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

18-79 years of age
Has been diagnosed by a clinician as having MS
Able to commit to the designated period of testing
Able to understand the informed consent process and provide consent to participate in the study
Capacity to complete study procedures as determined by screening personnel
A Brief Pain Inventory interference score of at least 3 or more.
SDMT Z-Score > -3.0
WRAT4 Standard Score > or = 85

Exclusion Criteria:

Visual, auditory, and motor deficits that would prevent full ability to understand study
Visual, auditory, and motor deficits that would prevent full ability to operate VR equipment
Uncontrolled epilepsy
Current diagnosis of vertigo
Uncontrolled mood disorders
History of Psychosis or Schizophrenia
Expanded Disability Status Scale (EDSS) Score greater than 6.5
Unable to tolerate or manipulate VR treatment procedures (as evidenced by VR capability assessment)

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

20

Study ID:

NCT03606668

Recruitment Status:

Completed

Sponsor:

NYU Langone Health

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

New York University School of Medicine
New York New York, 10016, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

20

Study ID:

NCT03606668

Recruitment Status:

Completed

Sponsor:


NYU Langone Health

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider